As part of an ongoing effort to track changes, the WHO Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) met yesterday to discuss BA sublines. 1 and BA.2. .
Based on available data on the impact of transmission, severity, recurrence, diagnosis, treatment and vaccination, the group stated that the BA.2 subline should continue to be considered as the concerning difference and classification as Omicron. The group added that BA.2 should be monitored by the Federal Department of Health in accordance with the separation from Omicron.
The omicron variant of current anxiety is key to the overall variability, including nearly all cases reported in GISAID. Omicron has a wide range of pathogens, each monitored by WHO and its partners. Most of them are BA.1, BA.1.1 (or Nextstrain clade 21K) and BA.2 (or Nextstrain clade 21L). It is known that the share of information according to BA.2 globally has increased compared to BA.1 in recent weeks, but the world around all variants is reduced.
BA.2 differs from BA.1 in genetic sequence, with some amino acids differing in spike proteins and other proteins. Studies have shown that BA.2 has better growth than BA.1. Further research is needed to understand the reasons for the benefits of this development, but preliminary data suggests that BA.2 is more contagious than BA.1, which is still the case, as most Omicron sublines now show . This export difference seems to be smaller, for example the difference between BA.1 and Delta. Moreover, although the BA.2 sequences increase proportionally compared to the other omicron sublines (BA.1 and BA.1.1), the decrease is still reported in all cases worldwide. Studies have measured the risk of success with BA.2 compared to BA.1. However, BA.1 examination, however, the review of BA.1, which is noted, but the first information of the population strongly against BA. 2 Strengthening BA.2 You can use the information.
By reaching the above standard decision, the tag-ve used animals that have no animal structure in Japan is made using the animal structure. There is also no difference between BA.2 and BA.1 in this case that is very high in South Africa, the United Kingdom and Denmark, the vaccine and the protected disease vaccine. ... for
As part of OMICRON, you can continue to monitor and evaluate the line of line and testing freedom and independence.
Or is regularly discussed and continued to talk about deformation and materials of pain and diagnosis, as well as the reaction.